We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Air Ambulance Upgrades Blood Glucose Monitoring System

By LabMedica International staff writers
Posted on 05 Mar 2012
An Air Ambulance company has upgraded its blood glucose monitoring system used across a wide range of glucose levels prior to, during, and after emergency flight transfers.

CEGA Air Ambulance is now using using Roche (Basel, Switzerland) Accu-Chek Inform II blood glucose monitoring strips. More...


The Accu-Chek Inform II test strips have undergone extensive evaluation, including studies at over 30 external sites as well as thorough internal testing. These evaluations demonstrated that the strips provide accurate and reliable blood glucose measurements under a variety conditions, including wide haematocrit and environmental ranges, and in presence of maltose.

The strips require a minimal sample volume of just 0.6 µL and deliver accurate results from alternative sampling sites, such as the palm and forearm.

The air company's senior flight nurse, Stuart Cox commented, "After reviewing all the kits that are available on the market, we felt that the Roche Accu-Chek Inform II test strips best met our requirements for high quality patient care in the air ambulance. The user interface is very simple and straightforward to use anywhere and by any of our trained staff. In addition, the strips have a very good range compared to other systems, giving accurate results at both high and low glucose levels, which is essential for patient safety.”

Stress-induced insulin resistance and hyperglycaemia is common in critically ill patients and close monitoring of blood glucose levels is an important part of their care. Studies have shown that maintenance of appropriate glycaemic control in such patients improves morbidity and mortality.

CEGA was established in 1973 as an air taxi service. Operations soon changed to meet a growing demand for worldwide repatriation of sick and injured holidaymakers and domestic National Health Service (NHS) transfers by Ambulance Aircraft.

Related Links:
CEGA Air Ambulance
Roche
National Health Service



Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Online QC Software
Acusera 24•7
Rapid Sepsis Test
SeptiCyte RAPID
Steam Sterilizer
Hi Vac II Line
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image: The study compares rapid molecular CPE diagnostics, which can return results in about one hour, with culture-based screening, which typically takes about 48 hours (Image credit: Adobe Stock)

Rapid Molecular Screening Aims to Accelerate Hospital Infection Control for CPE

Drug-resistant infections remain a critical patient-safety threat in hospitals, with carbapenemase-producing Enterobacterales (CPE) among the most urgent concerns. In England, reports of acquired carbapenemase... Read more

Pathology

view channel
Image: The VENTANA PTEN (SP218) RxDx Assay is a qualitative IHC assay for assessing PTEN protein in prostate adenocarcinoma, with staining performed using the OptiView DAB IHC Detection Kit on a BenchMark ULTRA instrument (Photo courtesy of Roche)

New Companion Diagnostic Expands Precision Medicine in Prostate Cancer

Prostate cancer is a leading cancer diagnosis in men and becomes particularly aggressive when it presents as metastatic, hormone-sensitive disease. Tumors with loss of phosphatase and tensin homolog (PTEN)... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.